AU5152900A - A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same - Google Patents
A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the sameInfo
- Publication number
- AU5152900A AU5152900A AU51529/00A AU5152900A AU5152900A AU 5152900 A AU5152900 A AU 5152900A AU 51529/00 A AU51529/00 A AU 51529/00A AU 5152900 A AU5152900 A AU 5152900A AU 5152900 A AU5152900 A AU 5152900A
- Authority
- AU
- Australia
- Prior art keywords
- maintained
- making
- pharmaceutical composition
- active agent
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31744899A | 1999-05-24 | 1999-05-24 | |
| US09317448 | 1999-05-24 | ||
| PCT/US2000/014049 WO2000071098A1 (en) | 1999-05-24 | 2000-05-23 | A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5152900A true AU5152900A (en) | 2000-12-12 |
Family
ID=23233696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU51529/00A Abandoned AU5152900A (en) | 1999-05-24 | 2000-05-23 | A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1185251A1 (en) |
| AU (1) | AU5152900A (en) |
| WO (1) | WO2000071098A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1465601A4 (en) | 2001-12-28 | 2006-02-15 | Teva Pharma | A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
| WO2006119779A2 (en) * | 2005-05-10 | 2006-11-16 | Lifecycle Pharma A/S | A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
| KR20160033796A (en) | 2006-03-28 | 2016-03-28 | 자블린 파머슈티칼스 인코포레이티드 | Formulations of low dose diclofenac and beta-cyclodextrin |
| WO2011130500A1 (en) * | 2010-04-16 | 2011-10-20 | Novartis Ag | Formulations of a pyridazine bipyrazinyl |
| WO2011133675A1 (en) * | 2010-04-21 | 2011-10-27 | Teva Pharmaceutical Industries Ltd. | Gabapentin enacarbil compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241417B (en) * | 1990-03-06 | 1994-01-14 | Vectorpharma Int | THERAPEUTIC COMPOSITIONS WITH CONTROLLED RELEASE OF DRUGS SUPPORTED ON CROSS-LINKED POLYMERS AND COATED WITH POLYMER FILM, AND THEIR PREPARATION PROCESS |
| US5399584A (en) * | 1992-05-05 | 1995-03-21 | The Procter & Gamble Company | Use of flavone derivatives for gastroprotection |
| US5993860A (en) * | 1993-06-17 | 1999-11-30 | Venture Lending | NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants |
| US5788987A (en) * | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
| EP0919234A3 (en) * | 1997-10-17 | 1999-08-25 | Eli Lilly And Company | Potentiation of pharmaceuticals by moxonidine |
-
2000
- 2000-05-23 AU AU51529/00A patent/AU5152900A/en not_active Abandoned
- 2000-05-23 EP EP00936175A patent/EP1185251A1/en not_active Withdrawn
- 2000-05-23 WO PCT/US2000/014049 patent/WO2000071098A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1185251A1 (en) | 2002-03-13 |
| WO2000071098A1 (en) | 2000-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2466099A (en) | Pharmaceutically active compounds and methods of use thereof | |
| AU1740195A (en) | Compositions and devices for controlled release of active ingredients | |
| AU4338099A (en) | Pharmaceutical composition containing a salt of acetaminophen and at least one other active ingredient | |
| AU2001263264A1 (en) | Tablets and methods for modified release of hydrophilic and other active agents | |
| AU2599501A (en) | Device and active component for inhibiting formation of thrombus-inflammatory cell matrix | |
| PL341589A1 (en) | Composition containing a crystalographically stable amorphous cephalosporin and method of obtaining same | |
| AU4303600A (en) | Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate | |
| EP1115396A4 (en) | Pharmaceutically active compounds and methods of use thereof | |
| AU4658100A (en) | Skin-friendly absorbent articles and compositions | |
| HUP9700005A3 (en) | 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent | |
| AU3240000A (en) | Hydrophobic and particulate soil removal composition | |
| AU5565099A (en) | Pharmaceutical compositions and methods for use | |
| WO2001041823A8 (en) | Radioactive compositions and methods of use thereof | |
| EP1154997A4 (en) | Pharmaceutically active compounds and methods of use thereof | |
| AU5647199A (en) | Carboxylic acid derivatives and drugs containing the same as the active ingredient | |
| AU5965399A (en) | Pharmaceutically active composition | |
| IL138841A (en) | Composition in the form of extruded granules containing an organosilicone surfactant and an active ingredient | |
| HUP0004223A3 (en) | 4-oxo-butynic acids and pharmaceutical composition containing them as active agent | |
| AU5443499A (en) | Carboxylic acid derivatives and drugs containing the same as the active ingredient | |
| AU5152900A (en) | A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same | |
| AU2620600A (en) | Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human | |
| AU2962400A (en) | Cleaner composition and method of use thereof | |
| AU3708100A (en) | Method for protecting and/or controlled release of active ingredients | |
| AU2570001A (en) | Pharmaceutical composition and method for its manufacture | |
| AU4929500A (en) | Method for making products used in sequential micronutrition and uses of resulting products |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |